Central Kentucky Research Associates, Inc.

Summary

Central Kentucky Research Associates, Inc. is a medical facility located in Lexington, Kentucky. This center is recognized for care of Flu, Smoking, Type 2 Diabetes, Tobacco Chewing, Tobacco Use and other specialties. Central Kentucky Research Associates, Inc. is involved with conducting 128 clinical trials across 134 conditions. There are 3 research doctors associated with this hospital, such as Mark Adams, Richard M. Glover II, and Richard M Glover, MD.

Top PIs

Clinical Trials running at Central Kentucky Research Associates, Inc.

Type 2 Diabetes

Cardiovascular Disease

Atherosclerosis

COVID-19

Birth Control

Heart Disease

Coronary Artery Disease

Cerebrovascular Disease

Determination of Death

Chronic Renal Failure

Retatrutide

for Obesity

The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/m\^2 or higher and Atherosclerotic Cardiovascular Disease and/or chronic kidney disease. The study will last for about 5 years. Participants will have up to 27 clinic visits with the study doctor.

Recruiting

1 award

Phase 3

2 criteria

MK-2828

for Type 2 Diabetes

The purpose of this study is to learn about the safety and if people tolerate a study medicine called MK-2828. The study will also measure what happens to MK-2828 in the body of a person with type 2 diabetes (T2D) over time (pharmacokinetic or PK study), and how it affects the amount of high-sensitivity C-reactive protein (hsCRP) in a person's blood.

Recruiting

0 awards

Phase 1

2 criteria